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Fifty patients, 65 years ofage or older, with renovascular
disease were evaluated and treated between 1979 and
1981. Twenty-one patients were treated medically, 21
surgically and 8 with percutaneous transluminal angio-
plasty of the renal arteries. The age, sex, target organ
involvement, initial blood pressure and serum creatinine
were similar among the three groups.
Sixty-six percent of the medical group demonstrated
lower blood pressure. Ninety percent of the surgical group
demonstrated a cure or improved blood pressure, and
43% of the patients with percutaneous transluminal an-
gioplasty had improved blood pressure. Renal function
deteriorated in 50% of the medical group, 19% of the
Renovascular disease in the elderly has been largely ignored
despite the extensive published data on the management of
patients with atherosclerotic renal artery stenosis. The num-
ber of patients who are 65 years or older has increased
eightfold since the tum of the century, whereas the general
population has increased only threefold (I). In 1980, the
elderly made up 11% of the population, yet accounted for
29% of all health care costs (2). The elderly will constitute
an even larger percent of the population in the future.
Some investigators suggest that all patients with reno-
vascular disease above the age of 50 to 55 should be treated
conservatively because morbidity and mortality associated
with surgical therapy in this age group are excessive and
the chance of surgical cure small (3,4). To date , no reports
have focused exclusively on patients 65 years of age or
older with renovascular disease. We reviewed the records
of patients with renovascular disease treated at the Cleveland
Clinic Foundation between 1979 and 1981 and selected the
subgroup of patients aged 65 and older for analysis .
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surgical group and 25% of patients in the percutaneous
transluminal angioplasty group. There was one opera-
tive death in the surgical group and one death related
to percutaneous transluminal angioplasty.
The data demonstrate that old age itself is not a con-
traindication to surgery. If hypertension is resistant to
medical therapy, if the patient experiences undesirable
side effects from the medications or if renal function is
jeopardized, surgical therapy should be considered. More
experience with percutaneous transluminal angioplasty
is necessary to determine its precise role in managing
atherosclerotic renal vascular disease in the elderly.
(J Am CoU CardioI1985;5:1232-8)
Methods
Patients. Three hundred thirty-three patients with re-
novascular disease were evaluated between 1979 and 1981.
Of these patients, 50 were 65 years of age or older. Twenty-
one patients were treated medically, 21 surgically and 8
with percutaneous transluminal renal angioplasty. Three pa-
tients who underwent angioplasty later required surgery.
These three patients will be included in the angioplasty
group when changes in blood pressure and renal function
are evaluated. However, they will also be included in the
surgical group when surgical morbidity and mortality are
evaluated .
Transfemoral aortography was performed in all patients
and selective renal arteriography was performed in many of
the patients using the Seldinger technique . A significant
lesion was defined as narrowing of the renal artery by at
least 50%.
Clinical features (Table 1). Forty-nine patients were
white and I was black. Seventeen patients had had hyper-
tension for less than 5 years, 12 patients for 5 to 10 years
and 21 patients for more than 10 years .
Six patients had no clinical evidence of target organ in-
volvement. The remainder had one or more of the following:
transient ischemic attacks (8 patients), stroke (I) , myo-
cardial infarction (II), angina pectoris (15), left ventricular
hypertrophy (17), congestive heart failure (9) and peripheral
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Treatment p Value for
Medical (n = 21) Surgical (n = 21) Angioplasty (n = 8) Group Differences
Age 69.7 ± 0.78 69.1 ± 0.69 70.1 ± 1.40 NS
Sex
Male 13 12 4 NS
Female 8 9 4
Durationof hypertension (yr) 8.7 ± 2.29 10.7 ± 2.42 13.3 ± 3.97 NS
Target organ involvement 18 19 7 NS
Unilateral disease 12 7 0
Bilateral disease 9 14 8 0.06
Percent obstruction
Unilateral 80 90
Bilateral 85 90 90 NS
No. of patients with total occlusion 5 7 3 NS
of one renal artery
Follow-upperiod (mo) 18.6 ± 2.0t 18.3 ± 2.7 17.0:j: ± 3.2 NS
(range) (3 to 32) (I to 47) (9 to 30)
Initial systolic BP (mm Hg) 192 ± 6.3 184 ± 28 194 ± 17.1 NS
Initial diastolic BP (mm Hg) 98 ± 3.5 100 ± 3.8 III ± 6.4 NS
Initial serum creatinine (mg/dl) 2.0 ± 0.19 2.4 ± 0.31 2.9 ± 0.60 NS
*Values are expressed as mean ± SEM; tthree patients did not have serum creatinine measured on follow-up visits; :j:one patient died 6 days after
the procedure. BP = blood pressure.
*Three patientsunderwentpercutaneous transluminal angiography be-
fore renal revascularization; tcontralateral nephrectomy in one patient;
:j:bilateral bypass in one patient.
Fifteen patients underwent renal revascularization, in-
cluding three who had undergone previous renal angio-
plasty. Seven of the patients underwent aortic resection and
replacement and renal revascularization, six for abdominal
aortic aneurysm and one because of claudication and pain
at rest. Two patients underwent nephrectomy (Table 2). One
patient had an aortorenal bypass and contralateral nephrec-
tomy and one underwent bilateral renal revascularization.
Fifteen patients had renal artery revascularization, 14 had
unilateral bypass and 1had bilateral bypass. Operative death
was defined as any death occurring within the first 30 days
of surgery or any death judged to have resulted from the
operation, regardless of the time interval.
Patients were selected for surgical therapy or percuta-
neous transluminal angioplasty on the judgment of the at-
tending physicians. The usual criteria included: 1) poorly
controlled hypertension despite maximal antihypertensive
therapy, 2) intolerance to antihypertensive medications, 3)
vascular disease (36), Twenty-three patients had coronary
artery disease proved at cardiac catheterization. Seven pa-
tients underwent coronary bypass surgery (four in the med-
ical group, one in the surgical group and two in the angio-
plasty group). Carotid endarterectomy was performed in 11
patients because of angiographically proved carotid athero-
sclerosis (2 in the medical group, 7 in the surgical group
and 2 in the angioplasty group). When required, coronary
artery bypass surgery and carotid endarterectomy were per-
formed before renal revascularization. Most patients had
group I or II retinopathy (Keith-Wagener-Barker classifi-
cation); two patients had group III changes and none had
group IV changes. Nine patients had coexisting diabetes
mellitus and one patient was insulin-dependent.
Forty-nine patients had atherosclerotic renovascular dis-
ease and one had fibrous disease. Unilateral disease was
more common in the medical group. Bilateral disease oc-
curred twice as often as unilateral disease in the surgical
group. All eight patients who underwent angioplasty had
bilateral disease (Table 1).
Treatment. In the surgical group, 6 patients underwent
renal revascularization or nephrectomy for control of blood
pressure alone, 3 underwent revascularization for preser-
vation of renal function and 12 underwent revascularization
for both control of blood pressure and preservation of renal
function. In patients undergoing percutaneous transluminal
angioplasty, indications for the procedure were control of
blood pressure in one, preservation of renal function in three
and control of blood pressure and preservation of renal func-
tion in four.
Table 2. Type of Surgical Procedures Performed
Renal revascularization*
Aortorenal bypasst
Splenorenal and/or hepatorenal bypasst
lIeorenal bypass
Aortic replacement and renal revascularization
Abdominal aortic aneurysmresection
Aortoiliac bypass
Nephrectomy
15
7
2
8
6
I
6
I
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high grade bilateral renal artery stenosis, 4) high grade ste-
nosis to a solitary kidney, or 5) a kidney that was at least
9 cm in size.
Percutaneous transluminal angioplasty of the renal ar-
teries was performed by the method of Griintzig and co-
workers (5,6). Seven patients underwent unilateral dilation
and one patient had bilateral dilation .
Blood pressure. In the surgical and angioplasty groups,
blood pressure results were assessed as follows. A cure was
defined as a blood pressure of 140/90 mm Hg or less, the
patient requiring no medication at the latest follow-up study.
All patients considered to be cured were followed up from
4 to 47 months (mean 25.6). An improvement in blood
pressure was defined as: 1) a 15 mm Hg or greater decrease
in diastolic blood pressure on the same or less medication,
or 2) a decrease of less than 15 mm Hg but normotensive
on less medication. In patients treated medically, blood
pressure control was assessed by placing patients into one
of three groups: I) normotensive (::5140/90 mm Hg) on
medication, 2) lower blood pressure on more medication
(2: 15 mm Hg decrease in diastolic blood pressure), or 3)
no change in blood pressure level despite more medication.
Renal function. Improvement in renal function was de-
fined as a 20% decrease in serum creatinine , and deterio-
ration as a 20% increase in serum creatinine . 1125 iothala-
mate glomerular filtration rate was measured in I I patients
at the initial visit and at the latest follow-up study. Values
corresponded to the changes in serum creatinine in these II
patients . Renal function by isotopic techniques and renal
mass was not evaluated in a systematic fashion.
Measurements. Blood pressure was measured with a
mercury manometer. Patients were placed in the supine
position for 5 minutes, and two blood pressure readings
were obtained and averaged for the final blood pressure.
Serum creatinine determinations were performed by the
Technicon SMA-II autoanalyzer (Technicon Instruments,
Inc.) on the basis of the Jaffe reaction of alkaline picurate
and creatinine .
Renin determinations were performed using modifica-
tions of the New England Nuclear Radioimmunoassay Tech-
nique. To obtain renal vein renin measurements , a catheter
was placed in the high and low inferior vena cava and right
and left renal veins. Repeat samples were obtained 15 and
30 minutes after administering furosemide, 40 mg in-
travenously .
Statistical analysis. Statistical analysis was performed
using the chi-square test for categorical variables and anal-
ysis of variance for continuous variables. In some cases,
differences between groups were tested by Student's t test.
For characteristics such as blood pressure and renal function
that were measured several times, paired t tests were used
to assess the significance of change .
Results
Blood pressure response to therapy (Table 3). Fourteen
of the 21 patients in the medical group demonstrated im-
provement in blood pressure; 7 (33.3%) showed no change
in blood pressure despite receiving more medication. In
contrast , five patients in the surgical group were cured of
hypertension and required no medication at latest follow-
up study. The mean follow-up period in these five patients
was 25.6 months (range 4 to 47). Thirteen of the 20 surgical
patients demonstrated improvement in blood pressure con-
trol, while only 2 patients (10%) had no change in blood
pressure levels. In the renal angioplasty group, no patients
were cured. Three of the seven patients showed improve-
ment and four had no change in blood pressure . Of the three
patients in the angioplasty group who later underwent sur-
gery, two demonstrated an improvement in blood pressure
control. Blood pressure response could not be evaluated in
one patient from both the surgical group and the angioplasty
group who died shortly after the procedure . Blood pressures
were significantly lower at the latest follow-up study in the
medical and surgical groups (Fig . I). There were no sig-
nificant differences in blood pressure among the three groups.
Renal vein renin determinations were obtained in 28 pa-
tients and lateralized in 13 patients . However, there was no
statistical difference in blood pressure response between
those patients who demonstrated lateralization and those
who did not.
Renal function (Table 4). Renal function deteriorated
in nine patients (four had bilateral renal artery disease) in
the medical group during a follow-up period of 3 to 32
months (Fig. 2A). One patient requires long-term hemo-
dialysis , and four patients have advanced chronic renal fail-
Table 3. Blood Pressure Re sponse
Medical Surgical Angioplasty
(n = 21) (n = 20)* (n = 7)*
Normotensive on medication 7 (33.3 %) Cured 5 (25%) 0
Blood pressure lower on 7 (33.3%) Improved 13 (65%) 3 (43%)
more medication
No change in blood pressure 7 (33.3 %) No change 2 (10%) 4 (57%)
*One patient died soon after the procedure and blood pressure response could not be evaluated .
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PTA = percutaneous transluminal angioplasty.
ure. Renal function is unchanged in the remammg nine
patients. Three patients followed up by their family phy-
sicians did not have a serum creatinine determination after
evaluation at the Cleveland Clinic. Only four patients in the
surgical group demonstrated deterioration in renal function
(Fig. 2B). In 17 patients, there was either improvement or
stabilization of renal function during a follow-up period of
I to 47 months. This occurred despite no statistically sig-
nificant difference in serum creatinine at presentation among
the three groups (Table I). Fifteen patients in the surgical
group had revascularization specifically for preservation of
renal function. Fourteen (93%) demonstrated improvement
or stabilization of renal function (Fig. 2B). In the renal
Table 4. Changes in Renal Function
Medical Surgical Angioplasty
(n = 18)* (n = 21) (n = 8)
Improved 0 8 (38%) 2 (25%)
No change 9 (50%) 9 (43%) 4 (50%)
Worse 9 (50%)t 4 (I9%):j: 2 (25%)'
*'three patients did not have serum creatinine measured on follow-up
visits; tone patient requires long-term hemodialysis, and four patients have
advanced chronic renal failure; :j:one patient developed acute tubular ne-
crosis postoperatively and died; 'one patient requires long-term hemodialysis.
angioplasty group, six patients demonstrated improved or
stable renal function during a follow-up period of 9 to 30
months (Fig. 2C). In two patients renal function deterio-
rated. All three patients who initially underwent angioplasty
but later required surgery demonstrated stabilization of renal
function.
Morbidity. * Nonfatal complications occurred in six pa-
tients undergoing surgical therapy. Four patients developed
acute tubular necrosis (three nonoliguric and one oliguric).
Renal function returned to preoperative values in three pa-
tients. Two patients had an acute myocardial infarction in
the early postoperative period; both had known double ves-
sel coronary artery disease.
Three nonfatal complications (two large groin hemato-
mas and one false aneurysm of the femoral artery) occurred
in the eight patients who underwent angioplasty.
Mortality (Table 5). Early deaths. One patient with
severe generalized arteriosclerosis and bilateral renal artery
stenosis died of multisystem failure I month after surgery.
He had undergone resection of an abdominal aortic aneu-
rysm and unilateral renal artery revascularization. The op-
erative mortality rate for all surgically treated patients was
4%. One patient who underwent angioplasty had an acute
myocardial infarction 12 hours after the procedure and died
6 days later in cardiogenic shock.
*Three patients who underwent percutaneous transluminal angioplasty
first and renal revascularization later are considered in the surgical group
when surgical morbidity and mortality are evaluated.
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Table 5. Analysis of Deaths
Duration of
Follow-Up Previous Coronary Carotid
Patient to Death (mo) MI Arteriograms CABS Surgery Cause of Death
Medical Group
10 No Severe disease Yes Yes Post open heart surgery (stroke,
renal failure)
2 3 Yes ND No No Necrotizing vasculitis
3 31 Yes ND No No Myocardial infarction
4 20 Yes Severe disease No No Dissectinganeurysm
5 28 Yes Severe disease Yes No Cardiorespiratory arrest
6 21 No ND No No ?
SurgicalGroup
7 4 No ND No No Pulmonary embolus-metastatic
renal cell carcinoma
8 3.5 No ND No No ?
9 2 No Mild disease No No Retroperitoneal bleed
10 I No Mild disease No Yes Surgical death; acute
renal failure, bleeding
PTA Group
II 10 Yes ND No No Myocardial infarction
12 6 days No Severe disease No No Myocardial infarction
CABS = coronaryarterybypass surgery;MI = myocardial infarction; ND = notdone; ? = unknown; PTA = percutaneous transluminal angioplasty.
Late deaths. Six patients (29%) in the medical group
died between 3 and 31 months after their initial evaluation
at the Cleveland Clinic. Four of these deaths were secondary
to complications of atherosclerosis. In the surgical group,
three late deaths occurred 2 to 4 months postoperatively.
None of these late deaths was secondary to atherosclerotic
complications. The one late death in the angioplasty group
was secondary to an acute myocardial infarction 10 months
after the procedure.
Discussion
Review of prior studies. Management of atheroscle-
rotic renovascular disease may depend on the severity of
hypertension or level of renal function. Other factors that
influence the therapeutic decision include: severity of the
stenosing lesion, extent of extrarenal vascular disease and
age of the patient. Epidemiologic data clearly demonstrate
that the elderly hypertensive patient is at increased risk.
Stroke, coronary artery disease and congestive heart failure
are morbid events known to occur with increased frequency
in elderly hypertensive patients (7-9).
Some investigators (10) suggest that blood pressure con-
trol after renal revasc.ularization is directly related to the age
of the patient at the time of operation and therefore contend
that renovascular surgery should be limited to patients under
50 to 55 years because the chance of curing hypertension
is small (3,4) and the mortality rate is high (3). Others (11)
have demonstrated that patients with generalized arterio-
sclerosis exhibit a lower cure or improvement rate of hy-
pertension and a higher mortality rate when compared with
patients who have only localized arteriosclerotic renal artery
disease.
These conclusions have recently been challenged. Two
reports (12,13) clearly demonstrated that patients with re-
novascular disease and severe generalized atherosclerosis
may have a low operative mortality rate (0 to 2%) and
morbidity if perioperative care is meticulous and if poten-
tially dangerous coronary and cerebrovascular disease is
identified and corrected before renal revascularization. They
also showed that 91 to 95% of their patients benefited from
surgery with improved blood pressure control.
Only two reports (14,15) specifically dealt with reno-
vascular hypertension in the ..elderly." Although the cure
or improvement rate for hypertension and operative mor-
tality were acceptable, these reports did not really study the
"elderly" patient. The minimal age for inclusion in these
studies was 50 and 60 years, respectively. Most demogra-
phers define the geriatic population as those 65 years and
older (I). Our study is the first to look exclusively at patients
65 years or older with renovascular disease. There was no
significant difference among the medical, surgical and per-
cutaneous transluminal angioplasty groups with regard to
age, sex, duration of hypertension or target organ involve-
ment. All patients were characterized by advanced age and
most had generalized atherosclerosis (88%).
JACCVol. 5, No.5
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Effectof treatment on blood pressure control. In con-
trast to previous reports (3,10), 90% of our surgically treated
patients demonstrated improvement or cure of hypertension.
In the surgical group, all seven patients (100%) with uni-
lateral renal artery disease demonstrated either cure or im-
provement in blood pressure control. Eleven patients (85%)
with bilateral disease were cured or showed improvement.
Among the medically treated patients, 66% had lower blood
pressure at the latest follow-up study. The mean values for
systolic and diastolic blood pressure among the three groups
at presentation and at the latest follow-up study were not
statistically different (Fig. I).
Patients in the renal angioplasty group fared less well
in blood pressure control. Only 43% experienced improve-
ment, which is similar to the results we have obtained in
younger patients (16,17). The reasons for the unsatisfactory
results are unclear; however, many patients in this series
had undergone angioplasty specifically for preservation of
renal function.
Revascularization or percutaneous transluminal an-
gioplasty for preservation of renalfunction. Preservation
of renal function may be an important indication for renal
revascularization (13,18-21) or angioplasty (16,17,22,23).
In our series, 93% of patients who underwent revasculari-
zation and 71% of patients who underwent angioplasty dem-
onstrated improvement or stabilization of renal function. In
contrast, 50% of the medically treated patients demonstrated
deterioration in renal function. Because atherosclerotic renal
artery disease is known to progress in 36 to 63% (24-26)
of patients and lead to complete occlusion in 16% (26), it
is reasonable to consider renal revascularization in the el-
derly patient when renal function is threatened.
Operative mortality and morbidity. In the past, the
argument against surgical therapy in the elderly has been
that surgical risk is excessive (3). In fact, operative mortality
has ranged from 0 to 9.3% (10-13,27-29) in patients with
atherosclerotic disease. The lower figure reflects meticulous
perioperativecare (12). In 100consecutivepatients undergoing
renal revascularization at the Cleveland Clinic Foundation,
the operative mortality rate was 2% (13). The one operative
death in our series occurred in a patient who had undergone
resection of an abdominal aortic aneurysm and renal revas-
cularization, a procedure known to carry a higher surgical
risk than renal revascularization alone (30). No operative
deaths occurred with renal artery revascularization or neph-
rectomy alone.
The majority of the late deaths in the medical group were
secondary to atherosclerotic complications compared with
none of the late deaths in the surgical group. A higher late
death rate in medically treated patients has also been dem-
onstrated by Hunt and Strong (31).
Clinical implications. Our data demonstrate that old age
in itself is not a contraindication to surgery. The low op-
erative mortality rate suggests that a more aggressive ap-
proach to the elderly patient with renovascular disease should
be considered. At present we recommend initial medical
therapy for elderly patients with atherosclerotic renovascular
disease if blood pressure is well controlled and renal function
is stable and not jeopardized by bilateral lesions or severe
stenosis to a solitary kidney. However, if hypertension is
resistant to therapy, if the patient experiences undesirable
side effects from medications or if renal function is jeop-
ardized, surgical therapy should be considered. More ex-
perience with percutaneous transluminal angioplasty is nec-
essary to determine its precise role in managing atherosclerotic
renal vascular disease in the elderly.
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